mechanism of action of glp 1 agonist GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Mechanisms of GLP-1 Receptor Agonist-Induced
Description
Zhu B, Gong N, Fan H, Peng CS, Ding XJ, Jiang Y, Wang YX (2014) Lamiophlomis Rotata, an orally available tibetan herbal painkiller, specifically reduces pain hypersensitivity states through the activation of spinal glucagon-like peptide-1 receptors

Statements Author contributions DA: Resources, Funding acquisition, Formal analysis, Software, Conceptualization, Methodology, Writing original draft, Investigation, Data curation

Gibson-Helm M, Teede H, Dunaif A, Dokras A
Although the results look promising and have potential for a positive impact, there is always a chance that a change in medication could make you feel worse

This molecule is, however, analogous to GLP-1s, or glucagon-like peptides, in humans

They were randomly assigned in a 2:1 ratio, to 68 weeks of treatment with semaglutide (at a dose of 2.4 mg) or placebo, plus lifestyle intervention
